Results 161 to 170 of about 5,791,370 (216)

Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA. [PDF]

Pharmacoeconomics
Shah HA, Jutlla G, Herrera-Restrepo O, Graham J, Grace M, Khan SA, Kuylen E, Begum S, Verelst F, Kocaata Z.   +9 more
europepmc   +1 more source

Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025. [PDF]

Euro Surveill
Campbell H, Lucidarme J, Clark SA, Heymer EJ, Ribeiro S, Bai X, Ahmad S, Ramsay ME, Borrow R, Ladhani SN.   +9 more
europepmc   +1 more source

Global epidemiology of serogroup Y invasive meningococcal disease: a literature review. [PDF]

Epidemiol Infect
Tin Tin Htar M, Findlow J, Balmer P, Swerdlow D.   +3 more
europepmc   +1 more source

Correction to: Understanding the Sequelae of Invasive Meningococcal Disease in the United States. [PDF]

Infect Dis Ther
Marshall GS, McCormick ZL, Johns JS, Verduzco-Gutierrez M, Herrera-Restrepo O, Harrison LH.   +5 more
europepmc   +1 more source

Invasive Meningococcal Disease in Children: Outcomes and Risk Factors for Sequelae and Fatal Cases in Greece. [PDF]

Microorganisms
Poulikakos P, Kapnisis D, Xirogianni A, Liakou I, Tsolia M, Michos A, Mantadakis E, Papaevangelou V, Iliadis A, Gkentzi D, Nikolopoulou SK, Sdougka M, Charisi K, Bangeas A, Farmaki E, Tzanakaki G.   +15 more
europepmc   +1 more source

Understanding the Sequelae of Invasive Meningococcal Disease in the United States. [PDF]

Infect Dis Ther
Marshall GS, McCormick ZL, Johns JS, Verduzco-Gutierrez M, Herrera-Restrepo O, Harrison LH.   +5 more
europepmc   +1 more source

First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023. [PDF]

Euro Surveill
Foster K, Heymer EJ, Campbell H, Wilson E, Baldasera J, Lucidarme J, Clark SA, Bai X, Ahmad S, Borrow R, Ladhani SN.   +10 more
europepmc   +1 more source

Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare <i>porA</i> genosubtype (19-54, 15), Spain, March to April 2024. [PDF]

Euro Surveill
Abad R, Navarro C, García-Amil C, Montes M, Castañeda-García A, Cuadros JA, Galar A, Martin F, Mena E, Pérez de Madrid S, Román C, Soler M, Vázquez JA.   +12 more
europepmc   +1 more source

Twenty-Eight Years of Invasive Meningococcal Disease Surveillance in the Autonomous Province of Vojvodina, Serbia: Epidemiological Trends and Implications for Enhanced Surveillance and Vaccination Policy. [PDF]

Vaccines (Basel)
Ristić M, Vuković V, Pustahija T, Medić S, Dragovac G, Petrović V.   +5 more
europepmc   +1 more source

Initial Experiences with Invasive Meningococcal Disease: Insights from Survivors and Their Caregivers. [PDF]

Infect Dis Ther
Herrera-Restrepo O, Afroz N, Cabrera ES, Reaney M, Sowell FG, Kumar R, Stillman A, Wukovits P, Rodrigues M, Pinto SB, Kocaata Z, Onwude O.   +11 more
europepmc   +1 more source